[Adjuvant Radiotherapy Following Radical Prostatectomy for Prostate Cancer]

Overview

Journal Urologe A

Specialty Urology

Date 2015 Jul 12

PMID 26162275

Authors

S Schmidt

F Zengerling

Affiliations

Soon will be listed here.

References

Briganti A, Wiegel T, Joniau S, Cozzarini C, Bianchi M, Sun M . Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Eur Urol. 2012; 62(3):472-87. DOI: 10.1016/j.eururo.2012.04.056. View

Wiegel T, Bottke D, Steiner U, Siegmann A, Golz R, Storkel S . Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol. 2009; 27(18):2924-30. DOI: 10.1200/JCO.2008.18.9563. View

Wiegel T, Bartkowiak D, Bottke D, Bronner C, Steiner U, Siegmann A . Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial. Eur Urol. 2014; 66(2):243-50. DOI: 10.1016/j.eururo.2014.03.011. View

Walz J, Chun F, Klein E, Reuther A, Saad F, Graefen M . Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer. J Urol. 2008; 181(2):601-7. DOI: 10.1016/j.juro.2008.10.033. View

van der Kwast T, Bolla M, van Poppel H, van Cangh P, Vekemans K, Da Pozzo L . Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol. 2007; 25(27):4178-86. DOI: 10.1200/JCO.2006.10.4067. View

Pound C, Partin A, Eisenberger M, Chan D, Pearson J, Walsh P . Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999; 281(17):1591-7. DOI: 10.1001/jama.281.17.1591. View

Thompson I, Tangen C, Paradelo J, Lucia M, Miller G, Troyer D . Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol. 2009; 181(3):956-62. PMC: 3510761. DOI: 10.1016/j.juro.2008.11.032. View

Schroder F, Hugosson J, Roobol M, Tammela T, Zappa M, Nelen V . Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet. 2014; 384(9959):2027-35. PMC: 4427906. DOI: 10.1016/S0140-6736(14)60525-0. View

Bolla M, van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke T . Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet. 2012; 380(9858):2018-27. DOI: 10.1016/S0140-6736(12)61253-7. View

10.

Morgan S, Waldron T, Eapen L, Mayhew L, Winquist E, Lukka H . Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: a systematic review and meta-analysis. Radiother Oncol. 2008; 88(1):1-9. DOI: 10.1016/j.radonc.2008.04.013. View